Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Leukemia, Myeloid, Acute 7Myeloproliferative Disorders 3Myelodysplastic Syndromes 2Leukemia, Monocytic, Acute 2Sarcoma, Kaposi 1Rectal Neoplasms 1Leukemia, Myelomonocytic, Chronic 1HIV Infections 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Cancer Metastatic 1Acquired Immunodeficiency Syndrome 1

Interventions

Doxorubicin 5Filgrastim 4Zidovudine 3Vincristine 3Etoposide 3Valganciclovir 2Thalidomide 2Rituximab 2Mitoxantrone 2Interferon alpha-2 2Cyclophosphamide 2Bleomycin 2ziconotide 1vesnarinone 1tocilizumab 1tin etiopurpurin 1interferon gamma-1b 1human papillomavirus vaccine, L1 type 16, 18 1Vinblastine 1Tumor Necrosis Factor-alpha 1Sugars 1Semaxinib 1Ro 24-7429 1Ritonavir 1Prednisone 1Paclitaxel 1Nivolumab 1Mitoguazone 1Methotrexate 1Medical Marijuana 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Acquired Immunodeficiency Syndrome × Liposomes × Clear all
NCT00001059 2012-04-17

Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Completed
120 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡